Eloise Mastrangelo
Overview
Explore the profile of Eloise Mastrangelo including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
69
Citations
1248
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ferrara S, Braggiotti B, Mastrangelo E, Di Gennaro P, Bertoni G, Milani M
Biochem Biophys Res Commun
. 2025 Jan;
747():151281.
PMID: 39793398
Aldolases are crucial enzymes that catalyze the formation of carbon-carbon bonds in the context of the anabolic and catabolic pathways of various metabolites. The bacterium Pseudomonas fluorescens N3 can use...
2.
Baroni S, Carletti T, Donalisio M, Arduino I, Cazzaniga I, Giorgino T, et al.
Front Cell Infect Microbiol
. 2024 Dec;
14:1487604.
PMID: 39654978
Coronaviruses (CoVs) share key genomic elements critical for viral replication, suggesting the feasibility of developing therapeutics with efficacy across different viruses. In a previous work, we demonstrated the antiviral activity...
3.
Balboni A, dAngelo C, Collura N, Brusco S, Di Berardino C, Targa A, et al.
Sci Rep
. 2024 Sep;
14(1):20421.
PMID: 39227705
Glioblastoma (GBM) is the most common malignant primary brain cancer that, despite recent advances in the understanding of its pathogenesis, remains incurable. GBM contains a subpopulation of cells with stem...
4.
Puxeddu M, Donalisio M, Bugert J, Corona A, Cocomazzi P, Milani M, et al.
ACS Infect Dis
. 2024 Aug;
10(9):3158-3175.
PMID: 39096289
SARS-CoV-2 and HCoV-OC43 belong to the same β genus of the Coronaviridae family. SARS-CoV-2 was responsible for the recent COVID-19 pandemic, and HCoV-OC43 is the etiological agent of mild upper...
5.
Fagnani E, Boni F, Seneci P, Gornati D, Muzio L, Mastrangelo E, et al.
Comput Struct Biotechnol J
. 2024 Mar;
23:1088-1093.
PMID: 38487369
The stabilization of the retromer protein complex can be effective in the treatment of different neurological disorders. Following the identification of bis-1,3-phenyl guanylhydrazone as an effective new compound for the...
6.
Fagnani E, Cocomazzi P, Pellegrino S, Tedeschi G, Grassi Scalvini F, Cossu F, et al.
Structure
. 2024 Mar;
32(5):594-602.e4.
PMID: 38460521
Apoptosis-inducing factor (AIF), which is confined to mitochondria of normal healthy cells, is the first identified caspase-independent cell death effector. Moreover, AIF is required for the optimal functioning of the...
7.
Erba F, di Paola L, Di Venere A, Mastrangelo E, Cossu F, Mei G, et al.
Biomol Concepts
. 2023 Jun;
14(1).
PMID: 37377424
Tumor necrosis factor receptor-associated factor proteins (TRAFs) are trimeric proteins that play a fundamental role in signaling, acting as intermediaries between the tumor necrosis factor (TNF) receptors and the proteins...
8.
Fiore M, Mosconi M, Boni F, Parodi A, Salis A, Tasso B, et al.
Molecules
. 2023 Jan;
28(1).
PMID: 36615638
Inhibitor of Apoptosis Proteins (IAPs) are validated targets for cancer therapy, and the deregulation of their activities within the NF-κB pathway correlates with chemoresistance events, even after treatment with IAPs-antagonists...
9.
Milan Bonotto R, Boni F, Milani M, Chaves-Sanjuan A, Franze S, Selmin F, et al.
Viruses
. 2022 Jun;
14(6).
PMID: 35746629
Pyridobenzothiazolone derivatives are a promising class of broad-spectrum antivirals. However, the mode of action of these compounds remains poorly understood. The HeE1-17Y derivative has already been shown to be a...
10.
Cossu F, Camelliti S, Lecis D, Sorrentino L, Majorini M, Milani M, et al.
Comput Struct Biotechnol J
. 2021 Dec;
19:6366-6374.
PMID: 34938412
Inhibitors of apoptosis proteins (IAPs) are validated onco-targets, as their overexpression correlates with cancer onset, progression, diffusion and chemoresistance. IAPs regulate cell death survival pathways, inflammation, and immunity. Targeting IAPs,...